            Brown Announces Senate Passage Of FDA Legislation                                                                                                                               Press Release    Brown Announces Senate Passage Of FDA Legislation  May 9  2007  WASHINGTON  United States   D OH  today announced Senate passage of the Food and Drug Administration  FDA  Revitalization Act  S 1082   This legislation modifies rules governing the FDA  the agency that oversees all medical products consumers use and most food they eat  The FDA Revitalization Act is a comprehensive bill that establishes new drug safety measures  reauthorizes drug and device manufacturer user fees  and includes numerous other provisions intended to promote drug safety  speed the approval of new medicines and medical devices  and stop anti competitive behavior in the prescription drug marketplace  FDAs first responsibility is to safeguard the health of American consumers  Brown said  FDA has strayed from its public health mission  and this legislation will help it get back on track  It gives FDA more tools to prevent and stop drug safety incidents  reauthorizes measures that help assure timely access to medical breakthroughs  and launches new initiatives aimed at cleaning up the drug industrys act  Brown was instrumental in negotiations to add several important provisions to this bill  including safeguards to prevent drugmakers from using delaying tactics to prevent generic drugs from the market  provisions to spur the development of new antibiotics  and an innovative program aimed at encouraging the development of treatments for neglected diseases Senator Brown strongly supported an amendment to the bill that would have enabled safe importation of lower priced medicines from Canada and other developed countries  Opponents of this amendment launched a successful effort to add unrealistic certification requirements to the amendment that effectively prevent its implementation  I was disappointed  but not surprised  that the drug industry was able to kill the importation amendment   Their army of lobbyists and unrivaled political contributions continue to sway this Congress at the expense of U S  consumers  U S  businesses  and U S  taxpayers  Brown said  Breaking the drug industrys chokehold on federal policymaking may be an uphill battle  but its one thats worth fighting  This legislation would improve drug safety  which includes     Mandating a system to track effectiveness of drugs in the marketplace by using data from federal and private insurer health databases      Placing each new drug approved on a longer term safety monitoring plan      Requiring the FDA and drugmakers to work together to assure the safety of medicines before and after a new drug is approved for marketing      Giving the FDA more authority to prevent misleading drug ads      Limiting patient exposure to drugs whose risks may still be emerging      Improving the scientific environment for innovation at FDA      Increasing transparency of the drug approval process      Encouraging pharmaceutical companies to conduct clinical trials with children to determine accurate dosing of medications for childrens developing bodies      Giving pharmaceutical companies financial incentives to study the effects of their drugs in children      Improving medical devices approved for children      Reauthorizing the Prescription Drug User Fee Act and the Medical Device User Fee Act      Cracking down on frivolous citizen petitions intended to delay FDA approval of generic drugs     Creating new incentives for the development of treatments for neglected diseases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          